BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15770670)

  • 21. Chromosome 22q allelic losses at microsatellite loci in human astrocytic tumors.
    Muhammad AK; Yoshimine T; Maruno M; Tokiyoshi K; Takemoto O; Hayakawa T
    Neurol Med Chir (Tokyo); 1997 Aug; 37(8):606-10; discussion 611. PubMed ID: 9301196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.
    van Duin M; van Marion R; Vissers K; Watson JE; van Weerden WM; Schröder FH; Hop WC; van der Kwast TH; Collins C; van Dekken H
    Genes Chromosomes Cancer; 2005 Dec; 44(4):438-49. PubMed ID: 16130124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci.
    Buckley PG; Jarbo C; Menzel U; Mathiesen T; Scott C; Gregory SG; Langford CF; Dumanski JP
    Cancer Res; 2005 Apr; 65(7):2653-61. PubMed ID: 15805262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion at chromosome band 20p12.1 in colorectal cancer revealed by high resolution array comparative genomic hybridization.
    Davison EJ; Tarpey PS; Fiegler H; Tomlinson IP; Carter NP
    Genes Chromosomes Cancer; 2005 Dec; 44(4):384-91. PubMed ID: 16110499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses.
    Magnani I; Moroni RF; Roversi G; Beghini A; Pfundt R; Schoenmakers EF; Larizza L
    Cancer Genet Cytogenet; 2005 Sep; 161(2):140-5. PubMed ID: 16102584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma.
    Bar EE; Lin A; Tihan T; Burger PC; Eberhart CG
    J Neuropathol Exp Neurol; 2008 Sep; 67(9):878-87. PubMed ID: 18716556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
    Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
    Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
    Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
    Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survey of genetic alterations in gastrinomas.
    Yu F; Jensen RT; Lubensky IA; Mahlamaki EH; Zheng YL; Herr AM; Ferrin LJ
    Cancer Res; 2000 Oct; 60(19):5536-42. PubMed ID: 11034099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers.
    Gaasenbeek M; Howarth K; Rowan AJ; Gorman PA; Jones A; Chaplin T; Liu Y; Bicknell D; Davison EJ; Fiegler H; Carter NP; Roylance RR; Tomlinson IP
    Cancer Res; 2006 Apr; 66(7):3471-9. PubMed ID: 16585170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors.
    Assämäki R; Sarlomo-Rikala M; Lopez-Guerrero JA; Lasota J; Andersson LC; Llombart-Bosch A; Miettinen M; Knuutila S
    Genes Chromosomes Cancer; 2007 Jun; 46(6):564-76. PubMed ID: 17330260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High definition cytogenetics and oligonucleotide aCGH analyses of cisplatin-resistant ovarian cancer cells.
    Prasad M; Bernardini M; Tsalenko A; Marrano P; Paderova J; Lee CH; Ben-Dor A; Barrett MT; Squire JA
    Genes Chromosomes Cancer; 2008 May; 47(5):427-36. PubMed ID: 18273836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative evaluation of microsatellite marker, AP-PCR and CGH studies in primary renal cell carcinoma.
    Hoefling C; Schmidt H; Meinhardt M; Lohse A; Taubert H; Fuessel S; Schmidt U; Schuster K; Baretton G; Wirth MP; Meye A
    Int J Mol Med; 2004 Jun; 13(6):835-42. PubMed ID: 15138621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homozygous deletions may be markers of nearby heterozygous mutations: The complex deletion at FRA16D in the HCT116 colon cancer cell line removes exons of WWOX.
    Alsop AE; Taylor K; Zhang J; Gabra H; Paige AJ; Edwards PA
    Genes Chromosomes Cancer; 2008 May; 47(5):437-47. PubMed ID: 18273838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copy number gain at 8q12.1-q22.1 is associated with a malignant tumor phenotype in salivary gland myoepitheliomas.
    Vékony H; Röser K; Löning T; Ylstra B; Meijer GA; van Wieringen WN; van de Wiel MA; Carvalho B; Kok K; Leemans CR; van der Waal I; Bloemena E
    Genes Chromosomes Cancer; 2009 Feb; 48(2):202-12. PubMed ID: 19009612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas.
    Weber RG; Hoischen A; Ehrler M; Zipper P; Kaulich K; Blaschke B; Becker AJ; Weber-Mangal S; Jauch A; Radlwimmer B; Schramm J; Wiestler OD; Lichter P; Reifenberger G
    Oncogene; 2007 Feb; 26(7):1088-97. PubMed ID: 16909113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [From identification of genomic polymorphism to diagnostic and prognostic markers of human epithelial tumors].
    Braga EA; Kiselev LL; Zabarovskiĭ ER
    Mol Biol (Mosk); 2004; 38(2):179-90. PubMed ID: 15125222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas.
    Ichimura K; Vogazianou AP; Liu L; Pearson DM; Bäcklund LM; Plant K; Baird K; Langford CF; Gregory SG; Collins VP
    Oncogene; 2008 Mar; 27(14):2097-108. PubMed ID: 17934521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-resolution genome-wide mapping of genetic alterations in human glial brain tumors.
    Bredel M; Bredel C; Juric D; Harsh GR; Vogel H; Recht LD; Sikic BI
    Cancer Res; 2005 May; 65(10):4088-96. PubMed ID: 15899798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.